New Treatment Reverses Alzheimer’s Disease Signs
WEBDec 20, 2023 · PHILADELPHIA – A “chaperone” molecule that slows the formation of certain proteins reversed disease signs, including memory impairment, in a mouse model of Alzheimer’s disease, according to a study from researchers at the Perelman School of Medicine at the University of Pennsylvania.
Breakthrough Alzheimer’s Discovery: Scientists Discover New …
WEB9 hours ago · An international research team has identified a new mechanism involving astrocytes for treating Alzheimer’s disease (AD) and proposed a novel therapeutic target. In their study, the researchers revealed that the autophagy pathway in astrocytes (non-neuronal cells in the brain) removes amyloid-beta (Aβ) oligomers, the …
Second Alzheimer’s drug to slow disease’s progression may be ... - CNN
WEBJul 17, 2023 · The full approval this month of the Alzheimer’s drug Leqembi marked a historic shift in the treatment of the disease: For the first time, doctors have a medicine to prescribe that has been...
Start of new era for Alzheimer’s treatment — Harvard Gazette
WEBJun 5, 2023 · Researchers say we appear to be at the start of a new era for Alzheimer’s treatment. Trial results published in January showed that for the first time a drug has been able to slow the cognitive decline characteristic of the disease.
New breakthroughs on Alzheimer’s | MIT Technology Review
WEBJun 27, 2023 · New breakthroughs on Alzheimer’s MIT scientists have pinpointed the first brain cells to show signs of neurodegeneration in the disorder and identified a peptide that holds potential as a...
FDA fully approves Leqembi, first drug shown to slow Alzheimer's ...
WEBJul 6, 2023 · The first drug found to slow the progression of Alzheimer's disease has been granted full approval by the Food and Drug Administration.
New drug donanemab is 'a turning point in the ... - Alzheimer's …
WEBMonday 17 July 2023. Dr Richard Oakley, Associate Director of Research at Alzheimer’s Society, has called breakthrough Alzheimer's drug donanemab, 'a turning point', as the full trial results were revealed.
Lecanemab, the New Alzheimer’s Treatment: 3 Things To Know
WEBJul 24, 2023 · The Food and Drug Administration (FDA) recently granted full approval to a new Alzheimer’s treatment called lecanemab, which has been shown to moderately slow cognitive and functional decline in early-stage cases of the disease.
First Alzheimer’s drug to slow disease progression gets full FDA ...
WEBJul 7, 2023 · The US Food and Drug Administration on Thursday granted traditional full approval to the Alzheimer’s drug Leqembi, the first medicine proven to slow the course of the memory-robbing disease.
Drug donanemab seen as turning point in dementia fight - BBC
WEBJul 17, 2023 · Drug donanemab seen as turning point in dementia fight. 17 July 2023. Fergus Walsh and Michelle Roberts. BBC News. Getty Images. A new drug, donanemab, is being hailed as a turning point in the...